172 related articles for article (PubMed ID: 21675957)
1. Neuroprotective efficacy of the peroxisome proliferator-activated receptor-γ ligand in chronic cerebral hypoperfusion.
Sayan-Ozacmak H; Ozacmak VH; Barut F; Jakubowska-Dogru E
Curr Neurovasc Res; 2011 Aug; 8(3):190-9. PubMed ID: 21675957
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia.
Chu K; Lee ST; Koo JS; Jung KH; Kim EH; Sinn DI; Kim JM; Ko SY; Kim SJ; Song EC; Kim M; Roh JK
Brain Res; 2006 Jun; 1093(1):208-18. PubMed ID: 16696956
[TBL] [Abstract][Full Text] [Related]
4. Berberine Ameliorates Cognitive Impairment by Regulating Microglial Polarization and Increasing Expression of Anti-inflammatory Factors following Permanent Bilateral Common Carotid Artery Occlusion in Rats.
Tian Y; Zheng Y; Wang Q; Yan F; Tao Z; Zhao F; Wang Y; Huang Y; Li F; Du Y; Wang N; Luo Y
CNS Neurol Disord Drug Targets; 2022; 21(9):869-879. PubMed ID: 35142272
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.
Han L; Cai W; Mao L; Liu J; Li P; Leak RK; Xu Y; Hu X; Chen J
Stroke; 2015 Sep; 46(9):2628-36. PubMed ID: 26243225
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone attenuates inflammation and CA3 neuronal loss following traumatic brain injury in rats.
Liu H; Rose ME; Culver S; Ma X; Dixon CE; Graham SH
Biochem Biophys Res Commun; 2016 Apr; 472(4):648-55. PubMed ID: 26947332
[TBL] [Abstract][Full Text] [Related]
7. Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion.
Qu J; Zhou Q; Du Y; Zhang W; Bai M; Zhang Z; Xi Y; Li Z; Miao J
Br J Pharmacol; 2014 Aug; 171(15):3702-15. PubMed ID: 24758388
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Yi JH; Park SW; Brooks N; Lang BT; Vemuganti R
Brain Res; 2008 Dec; 1244():164-72. PubMed ID: 18948087
[TBL] [Abstract][Full Text] [Related]
9. The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.
Lee CH; Park OK; Yoo KY; Byun K; Lee B; Choi JH; Hwang IK; Kim YM; Won MH
J Neurol Sci; 2011 Jan; 300(1-2):120-9. PubMed ID: 20880548
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: new evidences on neuroprotection in a progressive Parkinson's disease model.
Carta AR; Frau L; Pisanu A; Wardas J; Spiga S; Carboni E
Neuroscience; 2011 Oct; 194():250-61. PubMed ID: 21839812
[TBL] [Abstract][Full Text] [Related]
11. Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusion.
Feng Z; Lu Y; Wu X; Zhao P; Li J; Peng B; Qian Z; Zhu L
J Ethnopharmacol; 2012 Nov; 144(2):313-21. PubMed ID: 23022689
[TBL] [Abstract][Full Text] [Related]
12. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion.
Farkas E; Institóris A; Domoki F; Mihály A; Luiten PG; Bari F
Brain Res; 2004 May; 1008(2):252-60. PubMed ID: 15145763
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents.
Tureyen K; Kapadia R; Bowen KK; Satriotomo I; Liang J; Feinstein DL; Vemuganti R
J Neurochem; 2007 Apr; 101(1):41-56. PubMed ID: 17394460
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats.
Sun H; Huang Y; Yu X; Li Y; Yang J; Li R; Deng Y; Zhao G
Int J Dev Neurosci; 2008 Aug; 26(5):505-15. PubMed ID: 18455351
[TBL] [Abstract][Full Text] [Related]
15. Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion.
Annaházi A; Mracskó E; Süle Z; Karg E; Penke B; Bari F; Farkas E
Eur J Pharmacol; 2007 Oct; 571(2-3):120-8. PubMed ID: 17597609
[TBL] [Abstract][Full Text] [Related]
16. Post-ischemic administration of diazoxide attenuates long-term microglial activation in the rat brain after permanent carotid artery occlusion.
Farkas E; Timmer NM; Domoki F; Mihály A; Luiten PG; Bari F
Neurosci Lett; 2005 Oct; 387(3):168-72. PubMed ID: 16026930
[TBL] [Abstract][Full Text] [Related]
17. PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
Al Rouq F; El Eter E
Exp Gerontol; 2014 Mar; 51():1-7. PubMed ID: 24373843
[TBL] [Abstract][Full Text] [Related]
18. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
[TBL] [Abstract][Full Text] [Related]
19. Effects of Scutellaria baicalensis on chronic cerebral hypoperfusion-induced memory impairments and chronic lipopolysaccharide infusion-induced memory impairments.
Hwang YK; Jinhua M; Choi BR; Cui CA; Jeon WK; Kim H; Kim HY; Han SH; Han JS
J Ethnopharmacol; 2011 Sep; 137(1):681-9. PubMed ID: 21718777
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
Sain H; Sharma B; Jaggi AS; Singh N
Neuroscience; 2011 Sep; 192():322-33. PubMed ID: 21777659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
